Discovering New Medicines

In The News

July 12, 2022

Tetra Therapeutics Initiates Phase 2b/3 Clinical Studies of Investigational Drug BPN14770 in Fragile X Syndrome

July 23, 2021

Tetra Therapeutics CEO Mark Gurney retires

July 23, 2021

Tetra Therapeutics Announces Retirement of Mark Gurney and Names Chad Coberly Chief Executive Officer in Planned Succession

July 11, 2021

Decades-long quest to beat Fragile X fueled by persistence, science and relentless optimism

April 30, 2021

Experimental Treatment Boosts Cognitive Function in Fragile X Syndrome

NPR

April 29, 2021

Memory Loss Drug Appears To Help People With The Genetic Disease Fragile X

April 29, 2021

Treatment Found to Improve Cognitive Function in Patients With Fragile X Syndrome

April 29, 2021

Drug boosts cognition in men with fragile X syndrome

April 29, 2021

Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial

April 29, 2021

Fragile X Treatment Shows Promise in Phase II Trial

April 22, 2021

Researchers take a big step in treating a genetic disorder closely linked to autism.

Press Releases

Podcast

The Bio Report
January 2, 2020
Stabilizing Neuronal Connections to Treat Cognitive Impairment in Alzheimer’s

BioTech Nation Radio
April 3, 2019
Treatments for Fragile X, Alzheimer’s disease, and traumatic brain injury.

Awards

Michigan Celebrates
May 3, 2018
Michigan 50 Company to Watch 2018

GRBJ
December 12, 2016
2016 Newsmaker of the Year finalists

PM360
December 21, 2016
Innovators 2016: Startups